Vancomycin susceptibility as an aid to the identification of lactobacilli

Letters in Applied Microbiology

Volumn 26, Issue 2, 1998, Pages 153-154

  Hamilton Miller, J M T ^a   Shah, S ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ISOLATES; DIFFERENTIAL SUSCEPTIBILITY; LACTOBACILLUS ACIDOPHILUS; PROBIOTICS; SPECIES SPECIFICS; VANCOMYCIN;

BACILLI;

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTOBACILLUS; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; POSIBACTERIA;

EID: 0031981678     PISSN: 02668254     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-765X.1998.00297.x     Document Type: Article

References (11)

1. Aguirre, M. and Collins, M.D. (1993) Lactic acid bacteria and human clinical infection. Journal of Applied Bacteriology 75, 95-107.
2. Billot-Klein, D., Gutmann, L., Sable, S., Guittet, E. and van Heijenoort, J. (1994) Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides and Enterococcus gallinarum. Journal of Bacteriology 176, 2398-2405.
3. Cooper, G.L. and Given, D.B. (1986) Vancomycin. A Comprehensive Review of 30 Years Clinical Experience. New York: John Wiley.
4. Gherna, R., Pienta, P. and Cote, R. (1989) Catalogue of Bacteria and Bacteriophages, 17th edn. Rockville, MD: American Type Culture Collection.
5. Hamilton-Miller, J.M.T., Shah, S. and Smith, C.T. (1996) 'Probiotic' remedies are not what they seem. British Medical Journal 312, 55-56.
6. Handwerger, S., Pucci, M.J., Volk, K.J., Liu, J. and Lee, M.S. (1994) Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cvtoplasmic peptidoglycan precursors that terminate in lactate. Journal of Bacteriology 176, 260-264.
7. Harty, D.W.S., Patrikakis, M. and Knox, K.W. (1993) Identification of Lactobacillus strains isolated from patients with infective endocarditis and comparison of their surface-associated properties with those of other strains of the same species. Microbial Ecology in Health and Disease 6, 191-201.
8. Holt, J.G., Krieg, N.R., Sneath, P.H.A., Staley, J.T. and. Williams, S.T. (1994) Bergey's Manual of Determinative Bacteriology, 9th edn. Baltimore: Williams & Wilkins.
9. Riebel, W.J. and Washington, J.A. (1990) Clinical and. microbiologic characteristics of pediococci. Journal of Clinical Microbiology 28, 1348-1355.
10. Sussman, J.I., Baron, E.J., Goldberg, S.M., Kaplan, M.H. and Pizzarello, R.A. (1986) Clinical manifestations and therapy of lactobacillus endocarditis: report of a case and review of literature. Reviews of Infectious Diseases 8, 771-776.
11. Woodford, N., Johnson, A.P., Morrison, D. and Speller, D.C.E. (1995) Current perspectives on glycopeptide resistance. Clinical Microbiological Reviews 8, 585-615.